Evidence map›Paper›PMID 38882229›Full record

ArticleCureus2024

Retrospective Analysis of Glioblastoma Outcomes.

Razvan Onciul, Corneliu Toader, Luca-Andrei Glavan, Razvan-Adrian Covache-Busuioc, Bogdan-Gabriel Bratu, Horia-Petre Costin, Antonio-Daniel Corlatescu, Alexandru Vladimir Ciurea, Matei Grama, Andreea-Anamaria Idu

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Razvan OnciulDepartment of Neurosurgery, University Emergency Hospital of Bucharest, Bucharest, ROU.
Corneliu ToaderDepartment of Neurosurgery, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Luca-Andrei GlavanDepartment of Neurosurgery, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Razvan-Adrian Covache-BusuiocDepartment of Neurosurgery, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Bogdan-Gabriel BratuDepartment of Neurosurgery, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Horia-Petre CostinDepartment of Neurosurgery, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Antonio-Daniel CorlatescuDepartment of Neurosurgery, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Alexandru Vladimir CiureaDepartment of Neurosurgery, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.
Matei GramaDepartment of Software, Syndical.io, Bucharest, ROU.
Andreea-Anamaria IduDepartment of Neurosurgery, Carol Davila University of Medicine and Pharmacy, Bucharest, ROU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective mono-center study focuses on 144 cases of glioblastoma treated over a time span of 12 years in our clinic in Romania. We offer critical insight into the dreadful aspect of this tumor by highlighting the principal characteristics such as localization, the genetic information of each case, progression-free survival (PFS), and overall survival (OS). A tenth of our patients underwent a second surgical procedure, providing a comparable OS to the other part of our study group, proving that surgical treatment as salvage therapy is a viable option. Also, our research reinforces the fact that utilizing the Karnofsky Performance Scale is a great predictor of patient outcomes in glioblastoma patients. Even though radiotherapy and chemotherapy have mild effects in the context of this oncological disease, our research shows that O

Indexed as

glioblastomaprognostic factorsrecurrencesurgerysurvival

Identifiers

PMID38882229
PMCPMC11180423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.